(Q37791923)

23 August 2017

The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome (English)

1 reference

23 August 2017

Donald S Silverberg

1

1 reference

23 August 2017

1 November 2011

1 reference

23 August 2017

Heart Failure Reviews

1 reference

23 August 2017

16

1 reference

23 August 2017

6

1 reference

23 August 2017

609-614

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-010-9194-2

23 August 2017

0 references

cites work

The role of correction of anaemia in patients with congestive heart failure: a short review

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Anemia and chronic heart failure implications and treatment options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Anemia and mortality in heart failure patients a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Iron metabolism in the anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Iron regulation and erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Iron deficiency: an ominous sign in patients with systolic chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Etiology of anemia in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Insulin sensitivity in African-American and white women: association with inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Erythropoiesis stimulating agents in heart failure patients with anemia: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

New avenues of exploration for erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

The non-haematopoietic biological effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Ferric carboxymaltose in patients with heart failure and iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Adaptive response of the heart to long-term anemia induced by iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9194-2

Intravenous iron alone for the treatment of anemia in patients with chronic heart failure

21 January 2018

1 reference

12 December 2020

The anemia of heart failure

1 reference

12 December 2020

ESAs in dialysis patients: are you a hedgehog or a fox?

1 reference

12 December 2020

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

1 reference

12 December 2020

Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure

1 reference

12 December 2020

Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients

1 reference

12 December 2020

The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review

1 reference

12 December 2020

Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia

1 reference

12 December 2020

Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency

1 reference

12 December 2020

Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?

1 reference

12 December 2020

Anemia and heart failure

1 reference

12 December 2020

Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure

1 reference

12 December 2020

10.1007/S10741-010-9194-2

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20865450